GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (NAS:INCR) » Definitions » FCF Margin %

INCR (Intercure) FCF Margin % : 0.00% (As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Intercure FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Intercure's Free Cash Flow for the three months ended in Jun. 2024 was $0.00 Mil. Intercure's Revenue for the three months ended in Jun. 2024 was $0.00 Mil. Therefore, Intercure's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Intercure's current FCF Yield % is -24.53%.

The historical rank and industry rank for Intercure's FCF Margin % or its related term are showing as below:

INCR' s FCF Margin % Range Over the Past 10 Years
Min: -444.95   Med: -19.91   Max: 8.11
Current: -25.52


During the past 13 years, the highest FCF Margin % of Intercure was 8.11%. The lowest was -444.95%. And the median was -19.91%.

INCR's FCF Margin % is ranked worse than
80.87% of 993 companies
in the Drug Manufacturers industry
Industry Median: 0.89 vs INCR: -25.52


Intercure FCF Margin % Historical Data

The historical data trend for Intercure's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure FCF Margin % Chart

Intercure Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -444.88 -19.90 7.33 8.11 -15.82

Intercure Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Dec23 Jun24
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -50.13 - - -

Competitive Comparison of Intercure's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intercure's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Intercure's FCF Margin % falls into.



Intercure FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Intercure's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-15.627/98.775
=-15.82 %

Intercure's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Intercure FCF Margin % Related Terms

Thank you for viewing the detailed overview of Intercure's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intercure Business Description

Traded in Other Exchanges
Address
85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670
Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations. The company has two segments namely: Cannabis segment and Biomed segment, out of which it derives maximum revenue from Cannabis segment.